The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO Italy 2020 | Italian perspective: managing lymphoma
Stefano Luminari, MD, (IRCCS) Reggio Emilia, Reggio Emilia, Italy, discusses the management of follicular, mantle cell, and marginal lymphoma in Italy, including local management with radiotherapy in patients with limited-stage disease, the use of immuno-chemotherapeutic agents as well as maintenance therapies in follicular lymphoma specifically. Dr Luminari also evaluates treatment approaches for relapsed lymphoma, including novel agents for relapsed/refractory disease such as lenalidomide. In the future, Dr Luminari highlights the benefit of chemotherapy-free approaches as well as CAR T-cell therapies that are being explored in clinical trials. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
